$7.7MSeries A, 18 February 2026
Series A to move drug programs toward clinical readiness and grow its pipeline over two years.
- Amount
- $7.7M
- Stage
- Series A
- Announced
- 18 February 2026
- Lead
- IAN Alpha Fund
- Other investors
- Speciale Invest, Tenacity Ventures, BYT Ventures
- Use of funds
- Series A to move drug programs toward clinical readiness and grow its pipeline over two years.
- Checked
- Matched to an official SEC filing
- Sources
- Peptris nets ₹70 Cr Series A for AI-led drug discovery yourstory.com
Peptris nets ₹70 Cr Series A for AI-led drug discovery inc42.com